US20020099067A1
(en)
*
|
1993-07-08 |
2002-07-25 |
Ulrich Posanski |
Pharmaceutical compositions for sparingly soluble therapeutic agents
|
GB9325445D0
(en)
|
1993-12-13 |
1994-02-16 |
Cortecs Ltd |
Pharmaceutical formulations
|
CH686865A5
(de)
*
|
1994-06-15 |
1996-07-31 |
Gergely Gerhard |
Pharmazeutische Zubereitung mit einem hydrophoben Wirkstoff und einem Brausesystem, sowie Verfahren zur Herstellung der Zubereitung.
|
US5545628A
(en)
*
|
1995-01-10 |
1996-08-13 |
Galephar P.R. Inc. |
Pharmaceutical composition containing fenofibrate
|
GB9525194D0
(en)
*
|
1995-12-12 |
1996-02-07 |
Zeneca Ltd |
Pharmaceutical composition
|
US5858401A
(en)
|
1996-01-22 |
1999-01-12 |
Sidmak Laboratories, Inc. |
Pharmaceutical composition for cyclosporines
|
US5955098A
(en)
*
|
1996-04-12 |
1999-09-21 |
Flemington Pharmaceutical Corp. |
Buccal non polar spray or capsule
|
GB9608719D0
(en)
*
|
1996-04-26 |
1996-07-03 |
Scherer Ltd R P |
Pharmaceutical compositions
|
WO1998000008A1
(en)
*
|
1996-06-28 |
1998-01-08 |
Novartis Ag |
Pesticidal compositions
|
US7255877B2
(en)
*
|
1996-08-22 |
2007-08-14 |
Jagotec Ag |
Fenofibrate microparticles
|
US6465016B2
(en)
*
|
1996-08-22 |
2002-10-15 |
Research Triangle Pharmaceuticals |
Cyclosporiine particles
|
US5788978A
(en)
*
|
1996-12-17 |
1998-08-04 |
Passeron; Eduardo Julio |
Injectable pulsatile ivermectin composition
|
FR2758459B1
(fr)
*
|
1997-01-17 |
1999-05-07 |
Pharma Pass |
Composition pharmaceutique de fenofibrate presentant une biodisponibilite elevee et son procede de preparation
|
WO1998047486A1
(fr)
*
|
1997-04-18 |
1998-10-29 |
Taisho Pharmaceutical Co., Ltd. |
Microemulsion
|
CA2285983A1
(en)
*
|
1997-04-29 |
1998-11-05 |
Bernard Charles Sherman |
Emulsion preconcentrate comprising a cyclosporin and acetylated monoglyceride
|
US20030133974A1
(en)
*
|
1997-07-01 |
2003-07-17 |
Curatolo William John |
Encapsulated solution dosage forms of sertraline
|
IS4518A
(is)
*
|
1997-07-09 |
1999-01-10 |
Lyfjathroun Hf, The Icelandic Bio Pharmaceutical Group |
Nýtt lyfjaform fyrir bóluefni
|
KR100509130B1
(ko)
*
|
1997-07-29 |
2005-08-18 |
파마시아 앤드 업존 캄파니 엘엘씨 |
친지성 화합물의 자가유화 제제
|
US6008191A
(en)
*
|
1997-09-08 |
1999-12-28 |
Panacea Biotec Limited |
Pharmaceutical compositions containing cyclosporin
|
US6187747B1
(en)
|
1997-09-08 |
2001-02-13 |
Panacea Biotech Limited |
Pharmaceutical composition comprising cyclosporin
|
US6346511B1
(en)
|
1997-09-08 |
2002-02-12 |
Panacea Biotec Limited |
Pharmaceutical composition comprising cyclosporin
|
US6054421A
(en)
*
|
1997-09-23 |
2000-04-25 |
Scimed Life Systems, Inc. |
Medical emulsion lubricant
|
US6281175B1
(en)
|
1997-09-23 |
2001-08-28 |
Scimed Life Systems, Inc. |
Medical emulsion for lubrication and delivery of drugs
|
US20030095926A1
(en)
*
|
1997-10-01 |
2003-05-22 |
Dugger Harry A. |
Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the gastrointestinal tract or urinary tract
|
US20030077229A1
(en)
*
|
1997-10-01 |
2003-04-24 |
Dugger Harry A. |
Buccal, polar and non-polar spray or capsule containing cardiovascular or renal drugs
|
US20040136914A1
(en)
*
|
1997-10-01 |
2004-07-15 |
Dugger Harry A. |
Buccal, polar and non-polar spray containing ondansetron
|
EP1029536B1
(de)
|
1997-10-01 |
2007-11-28 |
Novadel Pharma Inc. |
Nichtpolare Spray zur bukkalen Verabreichung
|
US20030082107A1
(en)
*
|
1997-10-01 |
2003-05-01 |
Dugger Harry A. |
Buccal, polar and non-polar spray or capsule containing drugs for treating an infectious disease or cancer
|
US20040136913A1
(en)
*
|
1997-10-01 |
2004-07-15 |
Dugger Harry A. |
Buccal, polar and non-polar spray containing sumatriptan
|
US20040136915A1
(en)
*
|
1997-10-01 |
2004-07-15 |
Dugger Harry A. |
Buccal, polar and non-polar spray containing atropine
|
US20050281752A1
(en)
*
|
1997-10-01 |
2005-12-22 |
Dugger Harry A Iii |
Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system
|
US20040141923A1
(en)
*
|
1997-10-01 |
2004-07-22 |
Dugger Harry A. |
Buccal, polar and non-polar spray containing alprazolam
|
US20090162300A1
(en)
*
|
1997-10-01 |
2009-06-25 |
Dugger Iii Harry A |
Buccal, polar and non-polar spray containing alprazolam
|
US20030095925A1
(en)
*
|
1997-10-01 |
2003-05-22 |
Dugger Harry A. |
Buccal, polar and non-polar spray or capsule containing drugs for treating metabolic disorders
|
US20030095927A1
(en)
*
|
1997-10-01 |
2003-05-22 |
Dugger Harry A. |
Buccal, polar and non-polar spray or capsule containing drugs for treating muscular and skeletal disorders
|
US20050163719A1
(en)
*
|
1997-10-01 |
2005-07-28 |
Dugger Harry A.Iii |
Buccal, polar and non-polar spray containing diazepam
|
US20050287075A1
(en)
*
|
1997-10-01 |
2005-12-29 |
Dugger Harry A Iii |
Buccal, polar and non-polar spray or capsule containing drugs for treating pain
|
US7632517B2
(en)
*
|
1997-10-01 |
2009-12-15 |
Novadel Pharma Inc. |
Buccal, polar and non-polar spray containing zolpidem
|
US20030190286A1
(en)
*
|
1997-10-01 |
2003-10-09 |
Dugger Harry A. |
Buccal, polar and non-polar spray or capsule containing drugs for treating allergies or asthma
|
US20050002867A1
(en)
*
|
1997-10-01 |
2005-01-06 |
Novadel Pharma Inc. |
Buccal, polar and non-polar sprays containing propofol
|
US20030077228A1
(en)
*
|
1997-10-01 |
2003-04-24 |
Dugger Harry A. |
Buccal, polar and non-polar spray or capsule containing drugs for treating endocrine disorders
|
US20050180923A1
(en)
*
|
1997-10-01 |
2005-08-18 |
Dugger Harry A.Iii |
Buccal, polar and non-polar spray containing testosterone
|
US20030185761A1
(en)
*
|
1997-10-01 |
2003-10-02 |
Dugger Harry A. |
Buccal, polar and non-polar spray or capsule containing drugs for treating pain
|
US20030077227A1
(en)
|
1997-10-01 |
2003-04-24 |
Dugger Harry A. |
Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system
|
US6063762A
(en)
*
|
1997-12-05 |
2000-05-16 |
Chong Kun Dang Corp. |
Cyclosporin-containing microemulsion preconcentrate composition
|
CN1149078C
(zh)
*
|
1998-02-09 |
2004-05-12 |
乔尔·博朗尼克 |
治疗慢性胃肠道炎症的制剂
|
AU764001B2
(en)
|
1998-05-29 |
2003-08-07 |
Skyepharma Canada Inc. |
Thermoprotected microparticle compositions and process for terminal steam sterilization thereof
|
FR2782006B1
(fr)
*
|
1998-08-07 |
2002-04-19 |
Gattefosse Ets Sa |
Composition a liberation prolongee apte a former une micro-emulsion
|
US6551613B1
(en)
*
|
1998-09-08 |
2003-04-22 |
Alza Corporation |
Dosage form comprising therapeutic formulation
|
JP3557579B2
(ja)
*
|
1998-09-11 |
2004-08-25 |
株式会社三協 |
ソフトカプセル剤
|
JP4809533B2
(ja)
|
1998-11-20 |
2011-11-09 |
オバン・エナジー・リミテッド |
分散し得るリン脂質で安定化されたミクロ粒子
|
CN1236813C
(zh)
|
1998-12-11 |
2006-01-18 |
药品处理公司 |
水难溶性药物的自乳化组合物
|
US6814977B1
(en)
|
1998-12-18 |
2004-11-09 |
Abbott Laboratories |
Formulations comprising lipid-regulating agents
|
US7014864B1
(en)
|
1998-12-18 |
2006-03-21 |
Abbott Laboratories |
Formulations comprising lipid-regulating agents
|
US6838091B2
(en)
|
1998-12-18 |
2005-01-04 |
Abbott Laboratories |
Formulations comprising lipid-regulating agents
|
JP2002532539A
(ja)
*
|
1998-12-18 |
2002-10-02 |
アボット・ラボラトリーズ |
脂質調節剤を含む新規な製剤
|
DE69939335D1
(de)
|
1998-12-30 |
2008-09-25 |
Dexcel Ltd |
Dispergierbares konzentrat zur verabreichung von cyclosporin
|
US6383517B1
(en)
|
1999-01-29 |
2002-05-07 |
Abbott Laboratories |
Process for preparing solid formulations of lipid-regulating agents with enhanced dissolution and absorption
|
US6368622B2
(en)
|
1999-01-29 |
2002-04-09 |
Abbott Laboratories |
Process for preparing solid formulations of lipid regulating agents with enhanced dissolution and absorption
|
US6180138B1
(en)
|
1999-01-29 |
2001-01-30 |
Abbott Laboratories |
Process for preparing solid formulations of lipid-regulating agents with enhanced dissolution and absorption
|
US20030026835A1
(en)
*
|
1999-02-15 |
2003-02-06 |
Sumitomo Pharmaceuticals Company Limited |
Tablets disintegrating rapidly in the oral cavity
|
US6267985B1
(en)
|
1999-06-30 |
2001-07-31 |
Lipocine Inc. |
Clear oil-containing pharmaceutical compositions
|
US6248363B1
(en)
*
|
1999-11-23 |
2001-06-19 |
Lipocine, Inc. |
Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
|
US6761903B2
(en)
|
1999-06-30 |
2004-07-13 |
Lipocine, Inc. |
Clear oil-containing pharmaceutical compositions containing a therapeutic agent
|
US6294192B1
(en)
|
1999-02-26 |
2001-09-25 |
Lipocine, Inc. |
Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
|
US7374779B2
(en)
*
|
1999-02-26 |
2008-05-20 |
Lipocine, Inc. |
Pharmaceutical formulations and systems for improved absorption and multistage release of active agents
|
ATE307808T1
(de)
*
|
1999-03-24 |
2005-11-15 |
Scherer Technologies Inc R P |
Pharmazeutische formulierungen mit verbesserter löslichkeit in wasser
|
US6616942B1
(en)
*
|
1999-03-29 |
2003-09-09 |
Soft Gel Technologies, Inc. |
Coenzyme Q10 formulation and process methodology for soft gel capsules manufacturing
|
AU4017500A
(en)
*
|
1999-03-31 |
2000-10-16 |
Abbott Laboratories |
Novel formulations comprising lipid-regulating agents
|
US6719999B2
(en)
|
1999-03-31 |
2004-04-13 |
Abbott Laboratories |
Formulations comprising lipid-regulating agents
|
JP2003520767A
(ja)
*
|
1999-03-31 |
2003-07-08 |
アボット・ラボラトリーズ |
脂質調整剤を含む新規製剤
|
GB9907715D0
(en)
*
|
1999-04-01 |
1999-05-26 |
Scherer Corp R P |
Pharmaceutical compositions
|
US6652880B1
(en)
|
1999-04-01 |
2003-11-25 |
R.P. Scherer Technologies, Inc. |
Oral pharmaceutical compositions containing long-chain triglycerides and liphophilic surfactants
|
US6383471B1
(en)
|
1999-04-06 |
2002-05-07 |
Lipocine, Inc. |
Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents
|
US6057289A
(en)
*
|
1999-04-30 |
2000-05-02 |
Pharmasolutions, Inc. |
Pharmaceutical composition comprising cyclosporin in association with a carrier in a self-emulsifying drug delivery system
|
US6465011B2
(en)
|
1999-05-29 |
2002-10-15 |
Abbott Laboratories |
Formulations comprising lipid-regulating agents
|
US6372251B2
(en)
*
|
1999-06-11 |
2002-04-16 |
Abbott Laboratories |
Formulations comprising lipid-regulating agents
|
US6982281B1
(en)
|
2000-11-17 |
2006-01-03 |
Lipocine Inc |
Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
|
US20030236236A1
(en)
*
|
1999-06-30 |
2003-12-25 |
Feng-Jing Chen |
Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
|
US20030235595A1
(en)
*
|
1999-06-30 |
2003-12-25 |
Feng-Jing Chen |
Oil-containing, orally administrable pharmaceutical composition for improved delivery of a therapeutic agent
|
ATE296091T1
(de)
*
|
1999-09-21 |
2005-06-15 |
Skyepharma Canada Inc |
Oberflächenmodifizierte teilchenförmige zusammensetzungen biologisch aktiver stoffe
|
WO2001030337A2
(en)
*
|
1999-10-22 |
2001-05-03 |
Orbon Corporation |
Ophthalmic formulation of dopamine antagonists
|
US20060034937A1
(en)
*
|
1999-11-23 |
2006-02-16 |
Mahesh Patel |
Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
|
US20030180352A1
(en)
*
|
1999-11-23 |
2003-09-25 |
Patel Mahesh V. |
Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
|
US6632429B1
(en)
|
1999-12-17 |
2003-10-14 |
Joan M. Fallon |
Methods for treating pervasive development disorders
|
US7732404B2
(en)
|
1999-12-30 |
2010-06-08 |
Dexcel Ltd |
Pro-nanodispersion for the delivery of cyclosporin
|
FR2803203B1
(fr)
*
|
1999-12-31 |
2002-05-10 |
Fournier Ind & Sante |
Nouvelles formulations galeniques du fenofibrate
|
US20020102301A1
(en)
*
|
2000-01-13 |
2002-08-01 |
Joseph Schwarz |
Pharmaceutical solid self-emulsifying composition for sustained delivery of biologically active compounds and the process for preparation thereof
|
US20050037073A1
(en)
*
|
2000-01-13 |
2005-02-17 |
Alpharx Inc. |
Solid self-emulsifying dosage form for improved delivery of poorly soluble hydrophobic compounds and the process for preparation thereof
|
GB0001449D0
(en)
*
|
2000-01-21 |
2000-03-08 |
Cortendo Ab |
Compositions
|
MXPA02009763A
(es)
*
|
2000-04-04 |
2003-03-27 |
Shionogi & Co |
Composiciones aceitosas las cuales contienen farmacos altamente solubles en grasa.
|
US6365181B1
(en)
|
2000-04-20 |
2002-04-02 |
Gattefosse Corporation |
Thixatropic gelatin carrier composition
|
AU6608701A
(en)
*
|
2000-06-21 |
2002-01-02 |
Audit Institute For Medical Services And Quality Assurance Gmbh |
Pharmaceutical preparations containing cyclosporines and neutral oils
|
US6623734B2
(en)
*
|
2000-06-22 |
2003-09-23 |
Soft Gel Technologies, Inc. |
Super absorption coenzyme Q10
|
AUPQ875700A0
(en)
*
|
2000-07-13 |
2000-08-03 |
Reflex Research Limited |
Combination compositions
|
US6491950B1
(en)
*
|
2000-08-07 |
2002-12-10 |
Kos Pharmaceuticals, Inc. |
Controlled release pharmaceutical composition
|
HUP0301668A2
(hu)
*
|
2000-08-10 |
2003-09-29 |
Delsys Pharmaceutical Corporation |
Hidrofób hatóanyagok javított szilárd adagolási formái
|
US20070053895A1
(en)
|
2000-08-14 |
2007-03-08 |
Fallon Joan M |
Method of treating and diagnosing parkinsons disease and related dysautonomic disorders
|
US8586094B2
(en)
|
2000-09-20 |
2013-11-19 |
Jagotec Ag |
Coated tablets
|
US8030002B2
(en)
|
2000-11-16 |
2011-10-04 |
Curemark Llc |
Methods for diagnosing pervasive development disorders, dysautonomia and other neurological conditions
|
GB0101198D0
(en)
|
2001-01-17 |
2001-02-28 |
Scherer Technologies Inc R P |
Ingestible compositions containing an odoriferous oil
|
WO2002069936A2
(en)
*
|
2001-03-02 |
2002-09-12 |
Dr. Reddy's Laboratories Ltd. |
Pharmaceutical composition of ibuprofen
|
AU2002240755B2
(en)
*
|
2001-03-13 |
2007-07-05 |
Angiotech International Ag |
Micellar drug delivery vehicles and uses thereof
|
US20030157170A1
(en)
*
|
2001-03-13 |
2003-08-21 |
Richard Liggins |
Micellar drug delivery vehicles and precursors thereto and uses thereof
|
EP1372394A1
(de)
*
|
2001-04-03 |
2004-01-02 |
Schering Corporation |
Fungizide zusammensetzung mit verbesserter bioverfügbarkeit
|
US7431710B2
(en)
|
2002-04-08 |
2008-10-07 |
Glaukos Corporation |
Ocular implants with anchors and methods thereof
|
DK1392254T3
(da)
*
|
2001-04-20 |
2007-07-02 |
Univ British Columbia |
Micelle-lægemiddelindgivelsessystem for hydrofobe lægemidler
|
AUPR510001A0
(en)
*
|
2001-05-18 |
2001-06-14 |
Jupitar Pty Ltd |
Formulation and method
|
US20040235935A1
(en)
*
|
2001-06-12 |
2004-11-25 |
Francis Vanderbist |
Oral pharmaceutical composition containing a statin derivative
|
EP1269994A3
(de)
*
|
2001-06-22 |
2003-02-12 |
Pfizer Products Inc. |
Pharmazeutische Zusammensetzungen die ein Arzneimittel und die Konzentration verbesserende Polymere enthalten
|
WO2003002095A1
(fr)
*
|
2001-06-28 |
2003-01-09 |
Chugai Seiyaku Kabushiki Kaisha |
Preparation d'une micro-emulsion de type huile-eau
|
CA2452412C
(en)
*
|
2001-06-29 |
2011-05-24 |
Medgraft Microtech, Inc. |
Biodegradable injectable implants and related methods of manufacture and use
|
CN1954807A
(zh)
*
|
2001-07-09 |
2007-05-02 |
佐纳根有限公司 |
富含反式克罗米酚的克罗米酚组合物
|
US7173064B2
(en)
*
|
2001-07-09 |
2007-02-06 |
Repros Therapeutics Inc. |
Methods and compositions with trans-clomiphene for treating wasting and lipodystrophy
|
US7737185B2
(en)
*
|
2001-07-09 |
2010-06-15 |
Repros Therapeutics Inc. |
Methods and compositions with trans-clomiphene
|
US6720002B2
(en)
*
|
2001-07-20 |
2004-04-13 |
R.P. Scherer Technologies, Inc. |
Antihistamine formulations for soft capsule dosage forms
|
US20050009762A1
(en)
*
|
2003-06-06 |
2005-01-13 |
Strobel Michael Albert |
Application of water and organic solvent soluble ivermectin for topical and oral use
|
GB0119480D0
(en)
*
|
2001-08-09 |
2001-10-03 |
Jagotec Ag |
Novel compositions
|
US6488952B1
(en)
|
2001-08-28 |
2002-12-03 |
John P. Kennedy |
Semisolid therapeutic delivery system and combination semisolid, multiparticulate, therapeutic delivery system
|
FR2829028B1
(fr)
*
|
2001-08-29 |
2004-12-17 |
Aventis Pharma Sa |
Association d'un antagoniste du recepteur cb1 et d'un produit qui active la neurotransmission dopaminergique dans le cerveau, les compositions pharmaceutiques les contenant et leur utilisation pour le traitement de la maladie de
|
US6479060B1
(en)
*
|
2001-09-04 |
2002-11-12 |
Healthpoint, Ltd. |
Elegant hydrogenated castor oil ointments
|
AU2002340847B2
(en)
*
|
2001-09-10 |
2007-09-13 |
F. Hoffmann-La Roche Ag |
Oily thixotropic formulations
|
GB0125061D0
(en)
*
|
2001-10-18 |
2001-12-12 |
Norton Healthcare Ltd |
Pharmaceutical composition
|
US6462083B1
(en)
|
2001-11-13 |
2002-10-08 |
Sarfaraz K. Niazi |
Suppository base
|
WO2003041632A2
(en)
|
2001-11-14 |
2003-05-22 |
Texas Tech University |
Eutectic-based self-nanoemulsified drug delivery system
|
EA008072B1
(ru)
*
|
2001-12-03 |
2007-02-27 |
Новацея, Инк. |
Фармацевтические составы, содержащие соединения активного витамина d
|
KR20030065831A
(ko)
*
|
2002-02-01 |
2003-08-09 |
주식회사 태평양 |
사이클로스포린을 함유한 지속 방출형 약학적 조성물
|
US8100844B2
(en)
*
|
2002-04-25 |
2012-01-24 |
Ultraflex Systems, Inc. |
Ambulating ankle and knee joints with bidirectional dampening and assistance using elastomeric restraint
|
US20050287203A1
(en)
*
|
2002-05-08 |
2005-12-29 |
Nijs De H |
Formulation comprising testosteron undecanoate and castor oil
|
US6890558B2
(en)
*
|
2002-05-31 |
2005-05-10 |
R.P. Scherer Technologies, Inc. |
Oral pharmaceutical composition for soft capsules containing vinorelbine and method of treatment
|
US20030232097A1
(en)
*
|
2002-06-17 |
2003-12-18 |
Strides Inc. |
Oily wax matrix suspension formulation comprising ibuprofen free acid and potassium salt of ibuprofen
|
US6855332B2
(en)
*
|
2002-07-03 |
2005-02-15 |
Lyfjathroun Hf. |
Absorption promoting agent
|
KR100533458B1
(ko)
*
|
2002-07-20 |
2005-12-07 |
대화제약 주식회사 |
파클리탁셀의 가용화용 조성물 및 그의 제조 방법
|
US20040023935A1
(en)
*
|
2002-08-02 |
2004-02-05 |
Dey, L.P. |
Inhalation compositions, methods of use thereof, and process for preparation of same
|
GB2391471B
(en)
*
|
2002-08-02 |
2005-05-04 |
Satishchandra Punambhai Patel |
Pharmaceutical compositions
|
US20040053895A1
(en)
*
|
2002-09-18 |
2004-03-18 |
Bone Care International, Inc. |
Multi-use vessels for vitamin D formulations
|
US20040058895A1
(en)
*
|
2002-09-18 |
2004-03-25 |
Bone Care International, Inc. |
Multi-use vessels for vitamin D formulations
|
US7148211B2
(en)
*
|
2002-09-18 |
2006-12-12 |
Genzyme Corporation |
Formulation for lipophilic agents
|
EP1569515A4
(de)
*
|
2002-10-23 |
2006-04-26 |
Glaxosmithkline Biolog Sa |
Malaria-impfverfahren
|
US7544674B2
(en)
*
|
2002-10-25 |
2009-06-09 |
Galderma S.A. |
Topical skin care composition
|
US7374772B2
(en)
*
|
2002-11-07 |
2008-05-20 |
Bommarito Alexander A |
Topical antifungal treatment
|
US20050026877A1
(en)
*
|
2002-12-03 |
2005-02-03 |
Novacea, Inc. |
Pharmaceutical compositions comprising active vitamin D compounds
|
TW200409644A
(en)
*
|
2002-12-04 |
2004-06-16 |
Bio Max Inc |
Improved carrier system for cyclosporin pharmaceutical compositions
|
US20040109826A1
(en)
*
|
2002-12-06 |
2004-06-10 |
Dey, L.P. |
Stabilized albuterol compositions and method of preparation thereof
|
WO2004062692A1
(en)
*
|
2003-01-13 |
2004-07-29 |
Solvay Pharmaceuticals B.V. |
Formulation of poorly water-soluble active substances
|
US7323206B1
(en)
|
2003-03-04 |
2008-01-29 |
B. Braun Medical Inc. |
Reagents and methods for all-in-one total parenteral nutrition for neonates and infants
|
WO2004084870A1
(en)
*
|
2003-03-28 |
2004-10-07 |
Sigmoid Biotechnologies Limited |
Solid oral dosage form containing seamless microcapsules
|
US20040191207A1
(en)
*
|
2003-03-31 |
2004-09-30 |
Lipari John M. |
Alpha-hydroxy acid ester drug delivery compositions and methods of use
|
GB0308732D0
(en)
*
|
2003-04-15 |
2003-05-21 |
Axcess Ltd |
Absorption enhancers
|
GB0308734D0
(en)
*
|
2003-04-15 |
2003-05-21 |
Axcess Ltd |
Uptake of macromolecules
|
US20050020546A1
(en)
*
|
2003-06-11 |
2005-01-27 |
Novacea, Inc. |
Pharmaceutical compositions comprising active vitamin D compounds
|
US20060189586A1
(en)
*
|
2003-06-11 |
2006-08-24 |
Cleland Jeffrey L |
Pharmaceutical compositions comprising active vitamin D compounds
|
EP1498123A1
(de)
*
|
2003-07-18 |
2005-01-19 |
Aventis Pharma S.A. |
Emulgierende Systeme enthaltend Azetidin Derivate
|
US7419996B2
(en)
*
|
2003-08-13 |
2008-09-02 |
The University Of Houston |
Parenteral and oral formulations of benzimidazoles
|
US20080089877A1
(en)
*
|
2003-08-14 |
2008-04-17 |
Udell Ronald G |
Super Absorption Coenzyme Q10
|
EP1670325A1
(de)
|
2003-09-29 |
2006-06-21 |
Soft Gel Technologies, Inc. |
Solubilisierter coq-10
|
US8124072B2
(en)
|
2003-09-29 |
2012-02-28 |
Soft Gel Technologies, Inc. |
Solubilized CoQ-10
|
US7169385B2
(en)
*
|
2003-09-29 |
2007-01-30 |
Ronald G. Udell |
Solubilized CoQ-10 and carnitine
|
WO2005037251A1
(en)
*
|
2003-10-17 |
2005-04-28 |
Amylin Pharmaceuticals, Inc. |
Self-emulsifying drug delivery systems for hydrophobic therapeutic compounds
|
FR2861261B1
(fr)
*
|
2003-10-22 |
2007-11-16 |
Adisseo France Sas |
Procede zootechnique pour l'administation d'un derive de vitamine e et formulation
|
FR2861992B1
(fr)
*
|
2003-11-10 |
2007-07-20 |
Sanofi Synthelabo |
Composition pharmaceutique destinee a l'administration orale d'un derive de pyrazole-3-carboxamide.
|
US8784869B2
(en)
|
2003-11-11 |
2014-07-22 |
Mattern Pharma Ag |
Controlled release delivery system for nasal applications and methods of treatment
|
DK1530965T3
(da)
*
|
2003-11-11 |
2006-07-17 |
Mattern Udo |
Kontrolleret frigivelsesleveringssystem til nasal applikation
|
US8062664B2
(en)
*
|
2003-11-12 |
2011-11-22 |
Abbott Laboratories |
Process for preparing formulations of lipid-regulating drugs
|
CN1257711C
(zh)
*
|
2003-12-05 |
2006-05-31 |
石药集团中奇制药技术(石家庄)有限公司 |
丁苯酞软胶囊及其制备工艺
|
US20080234343A1
(en)
*
|
2004-03-24 |
2008-09-25 |
Takeda Pharmaceutical Company |
Preparation with Elevated Content
|
US20060177512A1
(en)
*
|
2004-04-05 |
2006-08-10 |
Yihong Qiu |
Process for preparing formulations of lipid-regulating drugs
|
AU2005329255B2
(en)
*
|
2004-04-15 |
2010-09-30 |
Chiasma, Inc. |
Compositions capable of facilitating penetration across a biological barrier
|
US20070219131A1
(en)
*
|
2004-04-15 |
2007-09-20 |
Ben-Sasson Shmuel A |
Compositions capable of facilitating penetration across a biological barrier
|
US8758821B2
(en)
|
2004-05-04 |
2014-06-24 |
Hormos Medical Ltd. |
Oral formulations of ospemifene
|
CN1950071A
(zh)
*
|
2004-05-04 |
2007-04-18 |
霍尔莫斯医疗有限公司 |
ospemifene的新口服制剂
|
US8075910B2
(en)
*
|
2004-05-20 |
2011-12-13 |
Pbm Pharmaceuticals, Inc. |
Oral compositions comprising edible oils and vitamins and/or minerals and methods for making oral compositions
|
WO2005120517A1
(en)
*
|
2004-06-07 |
2005-12-22 |
Strides Arcolab Limited |
Stable liquid suspension formulation comprising synthetic steroids and process for producing the same
|
WO2006019916A1
(en)
*
|
2004-07-14 |
2006-02-23 |
Repros Therapeutics Inc. |
Trans-clomiphene for the treatment of benign prostate hypertrophy, prostate cancer, hypogonadism, elevated triglycerides and high cholesterol
|
WO2006024620A1
(en)
*
|
2004-08-31 |
2006-03-09 |
Akzo Nobel N.V. |
Method for pigment solubilisation, a pigment composition and its use
|
US20080124766A1
(en)
*
|
2004-09-24 |
2008-05-29 |
Yoshinori Kuboki |
Scaffold Material Capable of Inducing Biological Hard Tissue or Soft Tissue
|
PL1811979T3
(pl)
*
|
2004-09-27 |
2009-04-30 |
Sigmoid Pharma Ltd |
Mikrokapsułki zawierające metyloksantynę i kortykosteroid
|
US8026281B2
(en)
*
|
2004-10-14 |
2011-09-27 |
Lupin Atlantis Holdings, S.A. |
Treating metabolic syndrome with fenofibrate
|
EP1817012A2
(de)
*
|
2004-11-24 |
2007-08-15 |
Merck & Co., Inc. |
Flüssige und halbfeste pharmazeutische formulierungen für die orale verabreichung eines substituierten amids
|
EA014420B1
(ru)
*
|
2004-12-06 |
2010-12-30 |
Релайэнт Фармасьютикалз, Инк. |
Омега-3 жирные кислоты и дислипидемический агент для липидной терапии
|
EA200701228A1
(ru)
*
|
2004-12-06 |
2007-12-28 |
Релайэнт Фармасьютикалз, Инк. |
Стабильные композиции фенофибрата с эфирами жирных кислот
|
US20060140820A1
(en)
|
2004-12-28 |
2006-06-29 |
Udo Mattern |
Use of a container of an inorganic additive containing plastic material
|
BRPI0606528A8
(pt)
|
2005-02-04 |
2018-03-13 |
Repros Therapeutics Inc |
composição para uso no fabrico de medicamentos de tratamento da infertilidade masculina e uso da mesma
|
WO2006096806A2
(en)
*
|
2005-03-08 |
2006-09-14 |
Reliant Pharmaceutiacals, Inc. |
Treatment with statin and omega-3 fatty acids and a combination product thereof
|
CN101141953A
(zh)
|
2005-03-21 |
2008-03-12 |
伊瓦克斯制药有限公司 |
结晶抑制剂及其在明胶胶囊中的用途
|
RU2413508C2
(ru)
*
|
2005-03-22 |
2011-03-10 |
Репрос Терапьютикс Инк. |
Режимы дозирования транс-кломифена
|
US7276113B2
(en)
*
|
2005-04-07 |
2007-10-02 |
U.S. Cosmetics Corporation |
Self-emulsifying pigments
|
KR20080009201A
(ko)
*
|
2005-04-15 |
2008-01-25 |
클라루스 쎄러퓨틱스, 아이엔씨. |
소수성 약물의 약물전달시스템 및 이를 포함하는 조성물
|
US8492369B2
(en)
|
2010-04-12 |
2013-07-23 |
Clarus Therapeutics Inc |
Oral testosterone ester formulations and methods of treating testosterone deficiency comprising same
|
WO2006119660A1
(en)
*
|
2005-05-11 |
2006-11-16 |
Givaudan Sa |
Encapsulation method
|
ATE543489T1
(de)
*
|
2005-05-26 |
2012-02-15 |
Teva Womens Health Inc |
Orale dosierformen mit progesteron und verwendungs- und herstellungsverfahren dafür
|
JP4889262B2
(ja)
*
|
2005-08-19 |
2012-03-07 |
理研ビタミン株式会社 |
脂溶性薬剤組成物
|
US20080058282A1
(en)
|
2005-08-30 |
2008-03-06 |
Fallon Joan M |
Use of lactulose in the treatment of autism
|
SE0800638L
(sv)
*
|
2005-09-22 |
2008-06-10 |
Ramachandran Radhakrishnan |
Ny löslighetsförbättrare och användning därav
|
EP1959926A1
(de)
*
|
2005-10-25 |
2008-08-27 |
Abbott Laboratories |
Formulierung mit einem arzneimittel geringer wasserlöslichkeit und anwendungsverfahren
|
EP1942872A2
(de)
*
|
2005-11-04 |
2008-07-16 |
Eastman Chemical Company |
Carboxyalkylcelluloseester zur verabreichung von schwer löslichen pharmazeutischen wirkstoffen
|
EP1965764B1
(de)
|
2005-12-05 |
2011-07-13 |
Merck Sharp & Dohme Corp. |
Selbstemulgierende formulierungen von cetp-hemmern
|
EP2015632B1
(de)
*
|
2006-04-19 |
2015-12-02 |
Mist Pharmaceuticals, LLC |
Stabile wässrig-alkoholische mundsprayformulierungen und verfahren
|
EP2023957A2
(de)
*
|
2006-06-07 |
2009-02-18 |
Morton Grove Pharmaceuticals, Inc. |
Orale flüssige loratadinformulierungen und verfahren
|
WO2008015959A1
(fr)
*
|
2006-08-01 |
2008-02-07 |
Otsuka Pharmaceutical Co., Ltd. |
Composition pharmaceutique permettant une meilleure absorption d'une substance pharmacologiquement active
|
CA2558202A1
(en)
*
|
2006-09-14 |
2006-11-23 |
Reinhold W. Vieth |
Vitamin d compositions and method of administration to infants
|
CN101600417B
(zh)
|
2006-10-04 |
2012-05-30 |
M&P专利股份公司 |
用于神经递质的经鼻施用的控制释放递送系统
|
TWI367212B
(en)
*
|
2006-10-24 |
2012-07-01 |
Helsinn Healthcare Sa |
Dosage forms of palonosetron hydrochloride having improved stability and bioavailability
|
US20080171089A1
(en)
*
|
2006-12-22 |
2008-07-17 |
Blondino Frank E |
Stable anti-nausea oral spray formulations and methods
|
EP1961412A1
(de)
|
2006-12-27 |
2008-08-27 |
LEK Pharmaceuticals D.D. |
Selbstmikroemulgierende Arzneimittelabgabesysteme
|
US8343541B2
(en)
|
2007-03-15 |
2013-01-01 |
Soft Gel Technologies, Inc. |
Ubiquinol and alpha lipoic acid compositions
|
US10265265B2
(en)
*
|
2007-03-15 |
2019-04-23 |
Drug Delivery Solutions Limited |
Topical composition
|
DE102007015701A1
(de)
*
|
2007-03-19 |
2008-09-25 |
Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh |
Neue pharmazeutische Zusammensetzungen für die Lipolyse und Verfahren zu deren Herstellung
|
EP2380564B1
(de)
|
2007-04-04 |
2014-10-22 |
Sigmoid Pharma Limited |
Orale pharmazeutische Zusammensetzung
|
CA2685118C
(en)
|
2007-04-26 |
2016-11-01 |
Sigmoid Pharma Limited |
Manufacture of multiple minicapsules
|
JP2010526054A
(ja)
*
|
2007-05-01 |
2010-07-29 |
シグモイド・ファーマ・リミテッド |
併用医薬組成物
|
EP2152247A4
(de)
*
|
2007-05-10 |
2012-12-26 |
Novadel Pharma Inc |
Zusammensetzungen und verfahren gegen schlaflosigkeit
|
EP2008651A1
(de)
|
2007-06-26 |
2008-12-31 |
Drug Delivery Solutions Limited |
Biologisch erodierbares Patch
|
EP2200613B1
(de)
|
2007-09-21 |
2018-09-05 |
The Johns Hopkins University |
Phenazin-derivate und ihre verwendungen
|
EP2044930A1
(de)
*
|
2007-10-01 |
2009-04-08 |
Nestec S.A. |
Zusammensetzung zur Steuerung Lipase-katalysierter Reaktionen
|
EP2826475B1
(de)
|
2007-10-16 |
2019-03-20 |
Repros Therapeutics Inc. |
Trans-Clomiphen zur Behandlung von Diabetes bei hypogonodalen Männer
|
US7985325B2
(en)
*
|
2007-10-30 |
2011-07-26 |
Novellus Systems, Inc. |
Closed contact electroplating cup assembly
|
US20090162517A1
(en)
*
|
2007-12-21 |
2009-06-25 |
Chron-Si Lai |
Chilled Nutritional Emulsions
|
US20090162522A1
(en)
*
|
2007-12-21 |
2009-06-25 |
Chron-Si Lai |
Induced Viscosity Nutritional Emulsions Comprising A Carbohydrate-Surfactant Complex
|
US20090162494A1
(en)
*
|
2007-12-21 |
2009-06-25 |
Chron-Si Lai |
Method of Making Chilled Nutritional Emulsions
|
US8658163B2
(en)
*
|
2008-03-13 |
2014-02-25 |
Curemark Llc |
Compositions and use thereof for treating symptoms of preeclampsia
|
US8084025B2
(en)
|
2008-04-18 |
2011-12-27 |
Curemark Llc |
Method for the treatment of the symptoms of drug and alcohol addiction
|
US9320780B2
(en)
|
2008-06-26 |
2016-04-26 |
Curemark Llc |
Methods and compositions for the treatment of symptoms of Williams Syndrome
|
US20090324730A1
(en)
*
|
2008-06-26 |
2009-12-31 |
Fallon Joan M |
Methods and compositions for the treatment of symptoms of complex regional pain syndrome
|
EP2318035B1
(de)
|
2008-07-01 |
2019-06-12 |
Curemark, Llc |
Verfahren und zusammensetzungen zur behandlung von symptomen von neurologischen und geistesstörungen
|
US10776453B2
(en)
*
|
2008-08-04 |
2020-09-15 |
Galenagen, Llc |
Systems and methods employing remote data gathering and monitoring for diagnosing, staging, and treatment of Parkinsons disease, movement and neurological disorders, and chronic pain
|
PT2343982T
(pt)
|
2008-09-17 |
2017-07-04 |
Chiasma Inc |
Composições farmacêuticas e métodos de administração associados
|
US20100092447A1
(en)
*
|
2008-10-03 |
2010-04-15 |
Fallon Joan M |
Methods and compositions for the treatment of symptoms of prion diseases
|
EP2351566B1
(de)
*
|
2008-10-22 |
2014-12-10 |
Santen Pharmaceutical Co., Ltd |
Pharmazeutische zusammensetzung mit verbesserter aufnahme über den darmtrakt
|
FR2937537A1
(fr)
|
2008-10-29 |
2010-04-30 |
Centre Nat Rech Scient |
Nanoparticules de statine
|
EP2947100B1
(de)
|
2009-01-06 |
2019-05-08 |
Galenagen, LLC |
Orale Zusammensetzungen zur Behandlung oder Prävention von Infektionen durch E. Coli
|
US9107419B2
(en)
|
2009-01-06 |
2015-08-18 |
Curelon Llc |
Compositions and methods for treatment or prevention of Staphylococcus aureus infections and for the eradication or reduction of Staphylococcus aureus on surfaces
|
US11304960B2
(en)
*
|
2009-01-08 |
2022-04-19 |
Chandrashekar Giliyar |
Steroidal compositions
|
WO2010119319A1
(en)
|
2009-03-09 |
2010-10-21 |
Pronova Biopharma Norge As |
Compositions comprising a fatty acid oil mixture and a free fatty acid, and methods and uses thereof
|
US9011908B2
(en)
*
|
2009-04-06 |
2015-04-21 |
Banner Life Sciences Llc |
Progesterone solutions for increased bioavailability
|
US9056050B2
(en)
|
2009-04-13 |
2015-06-16 |
Curemark Llc |
Enzyme delivery systems and methods of preparation and use
|
US20100280031A1
(en)
*
|
2009-04-30 |
2010-11-04 |
Paul David |
Lipid formulation of apoptosis promoter
|
US8362013B2
(en)
*
|
2009-04-30 |
2013-01-29 |
Abbvie Inc. |
Salt of ABT-263 and solid-state forms thereof
|
US20100278921A1
(en)
*
|
2009-04-30 |
2010-11-04 |
Fischer Cristina M |
Solid oral formulation of abt-263
|
US20100297194A1
(en)
*
|
2009-04-30 |
2010-11-25 |
Nathaniel Catron |
Formulation for oral administration of apoptosis promoter
|
US8728516B2
(en)
*
|
2009-04-30 |
2014-05-20 |
Abbvie Inc. |
Stabilized lipid formulation of apoptosis promoter
|
DK2471518T3
(en)
|
2009-05-18 |
2017-12-04 |
Sigmoid Pharma Ltd |
COMPOSITION INCLUDING OIL DROPS
|
US10206813B2
(en)
|
2009-05-18 |
2019-02-19 |
Dose Medical Corporation |
Implants with controlled drug delivery features and methods of using same
|
TWI532484B
(zh)
*
|
2009-06-08 |
2016-05-11 |
艾伯維有限公司 |
包含凋亡促進劑之固態分散劑
|
TWI471321B
(zh)
*
|
2009-06-08 |
2015-02-01 |
Abbott Gmbh & Co Kg |
Bcl-2族群抑制劑之口服醫藥劑型
|
SI2442791T1
(sl)
|
2009-06-16 |
2020-03-31 |
Pfizer Inc. |
Dozirna oblika apiksabana
|
US9878036B2
(en)
|
2009-08-12 |
2018-01-30 |
Sigmoid Pharma Limited |
Immunomodulatory compositions comprising a polymer matrix and an oil phase
|
US9511125B2
(en)
|
2009-10-21 |
2016-12-06 |
Curemark Llc |
Methods and compositions for the treatment of influenza
|
BR112012015433B8
(pt)
|
2009-12-22 |
2020-03-03 |
Leo Pharma As |
composição farmacêutica substancialmente anidra para aplicação cutânea
|
SG181916A1
(en)
*
|
2009-12-22 |
2012-08-30 |
Abbott Lab |
Abt-263 capsule
|
WO2011082384A2
(en)
|
2009-12-31 |
2011-07-07 |
Differential Drug Development Associates, Llc |
Modulation of solubility, stability, absorption, metabolism, and pharmacokinetic profile of lipophilic drugs by sterols
|
HUE027298T2
(en)
*
|
2010-01-14 |
2016-10-28 |
Asarina Pharma Ab |
Pharmaceutical composition containing developed storage and dissolution properties containing 3-beta-hydroxy-5-alpha-pregnan-20-one
|
CA2690490C
(en)
*
|
2010-01-19 |
2012-06-26 |
Accucaps Industries Limited |
Pharmaceutical formulations of loratadine for encapsulation and combinations thereof
|
US20110218209A1
(en)
*
|
2010-03-06 |
2011-09-08 |
Paul Daniel Yered |
Nutrient delievry drug composition
|
CN103705462B
(zh)
*
|
2010-04-12 |
2016-08-31 |
克劳拉斯医疗有限公司 |
口服睾酮酯制剂以及包含其的治疗睾酮缺乏症的方法
|
ES2525520T3
(es)
*
|
2010-04-12 |
2014-12-26 |
Clarus Therapeutics, Inc. |
Formulaciones orales de éster de testosterona y métodos para tratar la deficiencia de testosterona con las mismas
|
US9375437B2
(en)
|
2010-06-18 |
2016-06-28 |
Lipocine Inc. |
Progesterone containing oral dosage forms and kits
|
MY158809A
(en)
*
|
2010-09-22 |
2016-11-15 |
Craun Res Sdn Bhd |
Pharmaceutical compositions for calanolides, their derivatives and analogues, and process for producing the same
|
US10695431B2
(en)
|
2010-10-29 |
2020-06-30 |
Infirst Healthcare Limited |
Solid solution compositions and use in cardiovascular disease
|
US9504664B2
(en)
|
2010-10-29 |
2016-11-29 |
Infirst Healthcare Limited |
Compositions and methods for treating severe pain
|
US9308213B2
(en)
|
2010-10-29 |
2016-04-12 |
Infirst Healthcare Limited |
Solid solution compositions and use in chronic inflammation
|
US9744132B2
(en)
|
2010-10-29 |
2017-08-29 |
Infirst Healthcare Limited |
Solid solution compositions and use in chronic inflammation
|
US11202831B2
(en)
|
2010-10-29 |
2021-12-21 |
Infirst Healthcare Limited |
Solid solution compositions and use in cardiovascular disease
|
US11224659B2
(en)
|
2010-10-29 |
2022-01-18 |
Infirst Healthcare Limited |
Solid solution compositions and use in severe pain
|
US11730709B2
(en)
|
2010-10-29 |
2023-08-22 |
Infirst Healthcare Limited |
Compositions and methods for treating severe pain
|
US10695432B2
(en)
|
2010-10-29 |
2020-06-30 |
Infirst Healthcare Limited |
Solid solution compositions and use in severe pain
|
US9271950B2
(en)
|
2010-10-29 |
2016-03-01 |
Infirst Healthcare Limited |
Compositions for treating chronic inflammation and inflammatory diseases
|
US9737500B2
(en)
|
2010-10-29 |
2017-08-22 |
Infirst Healthcare Limited |
Compositions and methods for treating severe pain
|
US8895536B2
(en)
|
2010-10-29 |
2014-11-25 |
Infirst Healthcare Ltd. |
Compositions and methods for treating chronic inflammation and inflammatory diseases
|
UA113500C2
(xx)
|
2010-10-29 |
2017-02-10 |
|
Одержані екструзією розплаву тверді дисперсії, що містять індукуючий апоптоз засіб
|
GB201020032D0
(en)
|
2010-11-25 |
2011-01-12 |
Sigmoid Pharma Ltd |
Composition
|
US20180153904A1
(en)
|
2010-11-30 |
2018-06-07 |
Lipocine Inc. |
High-strength testosterone undecanoate compositions
|
US9034858B2
(en)
|
2010-11-30 |
2015-05-19 |
Lipocine Inc. |
High-strength testosterone undecanoate compositions
|
US9358241B2
(en)
|
2010-11-30 |
2016-06-07 |
Lipocine Inc. |
High-strength testosterone undecanoate compositions
|
US20120148675A1
(en)
|
2010-12-10 |
2012-06-14 |
Basawaraj Chickmath |
Testosterone undecanoate compositions
|
JO3337B1
(ar)
|
2010-12-13 |
2019-03-13 |
Debiopharm Sa |
تركيبات صيدلية تشمل أليسبوريفير
|
GB2488788B
(en)
*
|
2011-03-07 |
2013-07-10 |
Natco Pharma Ltd |
Oral formulation of phenylaminopyrymidine compound with enhanced bioavailability and pharmacological response
|
CN103533962B
(zh)
|
2011-03-14 |
2018-05-18 |
药品配送方案有限公司 |
一种眼用组合物
|
MX362974B
(es)
|
2011-04-21 |
2019-02-28 |
Curemark Llc |
Compuestos para el tratamiento de alteraciones neuropsiquiatricas.
|
US20130040923A1
(en)
|
2011-05-13 |
2013-02-14 |
Trimel Pharmaceuticals Corporation |
Intranasal lower dosage strength testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorder
|
US20130045958A1
(en)
|
2011-05-13 |
2013-02-21 |
Trimel Pharmaceuticals Corporation |
Intranasal 0.15% and 0.24% testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorder
|
US9757388B2
(en)
|
2011-05-13 |
2017-09-12 |
Acerus Pharmaceuticals Srl |
Intranasal methods of treating women for anorgasmia with 0.6% and 0.72% testosterone gels
|
US8951996B2
(en)
|
2011-07-28 |
2015-02-10 |
Lipocine Inc. |
17-hydroxyprogesterone ester-containing oral compositions and related methods
|
UA113291C2
(xx)
|
2011-08-04 |
2017-01-10 |
|
Метаболіти транскломіфену і їх застосування
|
WO2013034436A1
(de)
*
|
2011-09-08 |
2013-03-14 |
Hexal Ag |
Pharmazeutische zusammensetzung zur oralen darreichung mit einem statin
|
WO2013049749A2
(en)
|
2011-09-29 |
2013-04-04 |
Plx Pharma Inc. |
pH DEPENDENT CARRIERS FOR TARGETED RELEASE OF PHARMACEUTICALS ALONG THE GASTROINTESTINAL TRACT, COMPOSITIONS THEREFROM, AND MAKING AND USING SAME
|
PL2782584T3
(pl)
|
2011-11-23 |
2021-12-13 |
Therapeuticsmd, Inc. |
Naturalne skojarzone hormonalne formulacje i terapie zastępcze
|
US9301920B2
(en)
*
|
2012-06-18 |
2016-04-05 |
Therapeuticsmd, Inc. |
Natural combination hormone replacement formulations and therapies
|
CN102525917B
(zh)
*
|
2012-01-04 |
2014-06-18 |
四川百利药业有限责任公司 |
一种尼莫地平胶束注射剂及其制备方法
|
EP2827839B1
(de)
|
2012-03-20 |
2019-02-27 |
Particle Dynamics International, LLC |
Dosierungsform auf basis eines gelierungsmittels
|
US10350278B2
(en)
|
2012-05-30 |
2019-07-16 |
Curemark, Llc |
Methods of treating Celiac disease
|
EP2858629A1
(de)
|
2012-06-08 |
2015-04-15 |
Leo Laboratories Limited |
Topische gelzusammensetzung mit einem ingenolderivat und einer lösungsmittelmischung
|
US10806697B2
(en)
|
2012-12-21 |
2020-10-20 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US20150196640A1
(en)
|
2012-06-18 |
2015-07-16 |
Therapeuticsmd, Inc. |
Progesterone formulations having a desirable pk profile
|
EP3909586A1
(de)
*
|
2012-06-18 |
2021-11-17 |
TherapeuticsMD, Inc. |
Lösliche östradiolkapsel zur vaginalen einführung
|
US10806740B2
(en)
|
2012-06-18 |
2020-10-20 |
Therapeuticsmd, Inc. |
Natural combination hormone replacement formulations and therapies
|
US20130338122A1
(en)
|
2012-06-18 |
2013-12-19 |
Therapeuticsmd, Inc. |
Transdermal hormone replacement therapies
|
DE102012105512A1
(de)
*
|
2012-06-25 |
2014-04-24 |
Hennig Arzneimittel Gmbh & Co. Kg |
Arzneiform zur verlängerten Freisetzung von Wirkstoffen
|
GB201212010D0
(en)
|
2012-07-05 |
2012-08-22 |
Sigmoid Pharma Ltd |
Formulations
|
EP2914294A1
(de)
|
2012-11-02 |
2015-09-09 |
Repros Therapeutics Inc. |
Trans-clomiphen zur verwendung in der krebstherapie
|
US9682148B2
(en)
|
2012-12-20 |
2017-06-20 |
Solural Pharma ApS |
Solid oral dosage form of testosterone derivative
|
US11266661B2
(en)
|
2012-12-21 |
2022-03-08 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US9180091B2
(en)
|
2012-12-21 |
2015-11-10 |
Therapeuticsmd, Inc. |
Soluble estradiol capsule for vaginal insertion
|
US10471072B2
(en)
|
2012-12-21 |
2019-11-12 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US11246875B2
(en)
|
2012-12-21 |
2022-02-15 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US10568891B2
(en)
|
2012-12-21 |
2020-02-25 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US10537581B2
(en)
|
2012-12-21 |
2020-01-21 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
GB201304662D0
(en)
|
2013-03-14 |
2013-05-01 |
Sigmoid Pharma Ltd |
Compositions
|
US20160000799A1
(en)
|
2013-02-21 |
2016-01-07 |
Dr. Reddy's Laboratories Ltd. |
Pharmaceutical compositions of cetp inhibitors
|
US11744838B2
(en)
|
2013-03-15 |
2023-09-05 |
Acerus Biopharma Inc. |
Methods of treating hypogonadism with transnasal testosterone bio-adhesive gel formulations in male with allergic rhinitis, and methods for preventing an allergic rhinitis event
|
CN105188670B
(zh)
|
2013-03-15 |
2018-11-02 |
马留斯医药有限责任公司 |
乳液制剂
|
CN103257192B
(zh)
*
|
2013-05-08 |
2014-12-24 |
北京满格医药科技有限公司 |
一种软胶囊的溶出度测定方法
|
US10201549B2
(en)
*
|
2013-06-14 |
2019-02-12 |
Professional Compounding Centers Of America (Pcca) |
Testosterone combined with anastrozole injection solutions
|
GB201319791D0
(en)
|
2013-11-08 |
2013-12-25 |
Sigmoid Pharma Ltd |
Formulations
|
EP2878311A1
(de)
*
|
2013-11-27 |
2015-06-03 |
Freund Pharmatec Ltd. |
Verbesserung der Löslichkeit für hydrophobe Wirkstoffe
|
US10245273B2
(en)
|
2013-12-26 |
2019-04-02 |
Clarus Therapeutics, Inc. |
Oral pharmaceutical products and methods of use combining testosterone esters with hypolipidemic agents
|
US10206932B2
(en)
|
2014-05-22 |
2019-02-19 |
Therapeuticsmd, Inc. |
Natural combination hormone replacement formulations and therapies
|
WO2015184173A1
(en)
|
2014-05-29 |
2015-12-03 |
Dose Medical Corporation |
Implants with controlled drug delivery features and methods of using same
|
WO2015193224A1
(en)
*
|
2014-06-17 |
2015-12-23 |
Merck Sharp & Dohme B.V. |
Stable formulations of testosterone undecanoate
|
JP6723166B2
(ja)
*
|
2014-06-19 |
2020-07-15 |
ソルラル ファーマ エーピーエス |
親油性の化合物の固体経口剤形
|
WO2016018993A1
(en)
|
2014-07-29 |
2016-02-04 |
Therapeuticsmd, Inc. |
Transdermal cream
|
WO2016033549A2
(en)
|
2014-08-28 |
2016-03-03 |
Lipocine Inc. |
(17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
|
WO2016033556A1
(en)
|
2014-08-28 |
2016-03-03 |
Lipocine Inc. |
BIOAVAILABLE SOLID STATE (17-β)-HYDROXY-4-ANDROSTEN-3-ONE ESTERS
|
ES2858517T3
(es)
|
2014-11-07 |
2021-09-30 |
Sublimity Therapeutics Ltd |
Composiciones que comprenden ciclosporina
|
US10238709B2
(en)
|
2015-02-03 |
2019-03-26 |
Chiasma, Inc. |
Method of treating diseases
|
US20180070612A1
(en)
*
|
2015-03-25 |
2018-03-15 |
Feng Wan |
Rumen by-pass animal feed composition and method of making same
|
US10799479B2
(en)
|
2015-04-10 |
2020-10-13 |
Bioresponse, L.L.C. |
Self-emulsifying formulations of DIM-related indoles
|
WO2016187355A1
(en)
*
|
2015-05-20 |
2016-11-24 |
Glaukos Corporation |
Therapeutic drug compositions and implants for delivery of same
|
RU2708254C2
(ru)
|
2015-05-28 |
2019-12-05 |
Др. Редди'С Лабораториз Лтд. |
Пероральная композиция целекоксиба для лечения боли
|
EP3310359A4
(de)
|
2015-06-22 |
2019-04-03 |
Lipocine Inc. |
17-hydroxyprogesteronesterhaltige orale zusammensetzungen und zugehörige verfahren
|
US10328087B2
(en)
|
2015-07-23 |
2019-06-25 |
Therapeuticsmd, Inc. |
Formulations for solubilizing hormones
|
US11925578B2
(en)
|
2015-09-02 |
2024-03-12 |
Glaukos Corporation |
Drug delivery implants with bi-directional delivery capacity
|
US11564833B2
(en)
|
2015-09-25 |
2023-01-31 |
Glaukos Corporation |
Punctal implants with controlled drug delivery features and methods of using same
|
EP3426352A4
(de)
|
2016-03-08 |
2019-11-13 |
Los Gatos Pharmaceuticals, Inc. |
Camptothecin-derivate und verwendungen davon
|
EP3426301A4
(de)
|
2016-03-08 |
2019-11-06 |
Los Gatos Pharmaceuticals, Inc. |
Verbundnanopartikel und verwendungen davon
|
WO2017173044A1
(en)
*
|
2016-04-01 |
2017-10-05 |
Therapeuticsmd Inc. |
Steroid hormone compositions in medium chain oils
|
AU2017239645A1
(en)
|
2016-04-01 |
2018-10-18 |
Therapeuticsmd, Inc. |
Steroid hormone pharmaceutical composition
|
AU2017239679A1
(en)
*
|
2016-04-01 |
2018-10-18 |
Therapeuticsmd, Inc. |
Steroid hormone pharmaceutical composition
|
EP3442479A1
(de)
|
2016-04-20 |
2019-02-20 |
Harold Alexander Heitzmann |
Vorrichtung zur verabreichung eines bioresorbierbaren okularen medikaments
|
CA3078723A1
(en)
|
2016-11-28 |
2018-05-31 |
Nachiappan Chidambaram |
Oral testosterone undecanoate therapy
|
CA3083555A1
(en)
|
2017-11-27 |
2019-05-31 |
Umecrine Cognition Ab |
Pharmaceutical formulation of 3.alpha.-ethynyl-3.beta.-hydroxyandrostan-17-one oxime
|
WO2019113461A1
(en)
*
|
2017-12-08 |
2019-06-13 |
Western University Of Health Sciences |
Lipid emulsified drug delivery systems for chemoprevention and treatment
|
CN110013467B
(zh)
*
|
2018-01-10 |
2021-09-17 |
上海汉都医药科技有限公司 |
一种固体微粒及其制备方法和含其的药物组合物
|
EP3542788A1
(de)
|
2018-03-19 |
2019-09-25 |
MC2 Therapeutics Limited |
Topische zusammensetzung enthaltend calcipotriol und betamethason dipropionat
|
US11266615B2
(en)
|
2018-06-08 |
2022-03-08 |
Harrow Ip, Llc |
Pyrimethamine-based pharmaceutical compositions and methods for fabricating thereof
|
WO2019236857A1
(en)
*
|
2018-06-08 |
2019-12-12 |
Harrow Health, Inc. |
Pyrimethamine-based pharmaceutical compositions and methods for fabricating thereof
|
BR112021007214A2
(pt)
|
2018-10-15 |
2021-08-10 |
Cipla Limited |
formulação farmacêutica
|
EP3952899A1
(de)
*
|
2019-04-11 |
2022-02-16 |
R.P. Scherer Technologies, LLC |
Formulierung zur oralen verabreichung von proteinen, peptiden und kleinen molekülen mit schlechter permeabilität
|
US11633405B2
(en)
|
2020-02-07 |
2023-04-25 |
Therapeuticsmd, Inc. |
Steroid hormone pharmaceutical formulations
|
EP4125820A4
(de)
|
2020-03-26 |
2024-04-10 |
Plx Opco Inc |
Pharmazeutische träger mit fähigkeit zur ph-abhängigen rekonstitution und verfahren zur herstellung und verwendung davon
|
US11541009B2
(en)
|
2020-09-10 |
2023-01-03 |
Curemark, Llc |
Methods of prophylaxis of coronavirus infection and treatment of coronaviruses
|
US11638714B2
(en)
|
2020-11-10 |
2023-05-02 |
Mountain Valley Md Inc |
Water dissolvable macrocyclic lactone cyclodextrin complexes
|
US11077134B1
(en)
|
2020-11-10 |
2021-08-03 |
Mountain Valley Md Inc |
Water dissolvable macrocyclic lactone cyclodextrin complexes
|
US11141457B1
(en)
|
2020-12-28 |
2021-10-12 |
Amryt Endo, Inc. |
Oral octreotide therapy and contraceptive methods
|
US11337987B1
(en)
|
2021-05-07 |
2022-05-24 |
Lipocine Inc. |
Compositions and methods for treating central nervous system disorders
|